Access cutting-edge treatment-resistant depression treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.
Access treatment-resistant depression specialists in New Haven at no cost
This study follows strict safety protocols and ethical guidelines
All study-related treatment-resistant depression treatment provided free
The purpose of this study is to compare the relative effectiveness, acceptability, and side effects of ketamine delivered through an IV (a drip into the arm) which is not currently FDA approved for use in the treatment of treatment-resistant depression (TRD) and Esketamine (Spravato®), taken as a nasal spray which has received FDA approval for use in the treatment of treatment-resistant depression (TRD) in the treatment of patients with treatment-resistant depression (TRD). The study will look a
Sponsor: Yale University
Check if you qualify for this treatment-resistant depression clinical trial in New Haven, CT
If you're searching for treatment-resistant depression treatment options in New Haven, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced treatment-resistant depression specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.